Add a beneficial impact on climate change to the long list of benefits being attributed to GLP-1 agonist medicines. An unusual study presented at the European Society of Cardiology (ESC) congress in ...

Discover which academic programs are still accepting applications for admission to upcoming sessions. Please note that programs may close at any point after the official deadline without warning. If ...

Abstract: Optimal control is a subject that dates back nearly 100 years. The roots of optimal control lie in the subject of variational calculus, which was originally invented by Leonhard Euler ...

New and revised clinical guidance spanning dyslipidemia, cardiovascular disease in pregnancy, valvular heart disease, myocarditis and pericarditis, and mental health was released as part of ESC ...

A new meta-analysis from Mattia Galli, MD, PhD, et al., of 21 trials using eight different GLP1-RAs and with nearly 100,000 patients found "conclusive high-certainty evidence" that, vs. controls, the ...